Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04050176
PHASE3

Use of Blinded Tapering for Hypnotic Discontinuation

Sponsor: National Jewish Health

View on ClinicalTrials.gov

Summary

The study will employ a randomized longitudinal clinical trial design to evaluate the relative efficacy of a blinded hypnotic tapering protocol when used in combination with therapist delivered Cognitive Behavioral Therapy for Insomnia (CBTI) for enhancing hypnotic discontinuation rates. A blinded SMT+CBTI intervention will be compared to open-label SMT+CBTI.

Key Details

Gender

All

Age Range

21 Years - Any

Study Type

INTERVENTIONAL

Enrollment

260

Start Date

2019-12-16

Completion Date

2026-06-30

Last Updated

2025-02-24

Healthy Volunteers

No

Interventions

BEHAVIORAL

Hypnotic Medication Open-Label Taper

Participants will have their soporific hypnotic medication dosage reduced by 25% every two weeks during a 10 week open-label tapering period.

BEHAVIORAL

Hypnotic Medication Blinded Taper

Participants will have their soporific hypnotic medication dosage reduced by 25% every two weeks during a 10 week blinded tapering period.

Locations (1)

National Jewish Health

Denver, Colorado, United States